Aly E Aly, MD | |
3366 Nw Expressway Bldg D, Suite 730, Oklahoma City, OK 73112-4462 | |
(405) 951-4944 | |
(405) 951-4955 |
Full Name | Aly E Aly |
---|---|
Gender | Male |
Speciality | Nephrology |
Experience | 42 Years |
Location | 3366 Nw Expressway Bldg D, Oklahoma City, Oklahoma |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1316940117 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RN0300X | Internal Medicine - Nephrology | 19742 (Oklahoma) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Integris Baptist Medical Center, Inc | Oklahoma city, OK | Hospital |
Integris Southwest Medical Center | Oklahoma city, OK | Hospital |
Integris Canadian Valley Hospital | Yukon, OK | Hospital |
Integris Health Edmond | Edmond, OK | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Kidney Specialists Of Central Oklahoma, Pc | 7618904988 | 17 |
News Archive
A U.S. government report released Tuesday says that a record number of Americans are getting tested for HIV but more than 200,000 Americans are infected and are unaware of their status. In 2009 82.9 million adults age 18 to 64 had been tested for HIV. This is 11.4 million more than the total in 2006. Also until 2009 45 percent of adults had been tested at least once in their lives, up from 40 percent four years ago. However 55 percent of adults, and 28.3 percent of adults at risk for HIV, have never been tested, according to the report.
Due to the rarity of advanced cutaneous squamous cell carcinoma (cSCC), staying current with the latest information on diagnosing, treating, and supporting patients with this diagnosis can be challenging for clinicians who do not often encounter advanced cSCC in practice.
Clinical Data, Inc. (NASDAQ: CLDA) today announced the Company's operational and financial results for its third fiscal quarter ended December 31, 2009, confirming its plans to submit a new drug application (NDA) for vilazodone for the treatment of depression this quarter.
HemCon Medical Technologies, Inc. is pleased to announce that its partner in Japan, Zeria Pharmaceutical Co., Ltd., has obtained regulatory clearance from the Ministry of Health Labor and Welfare for the HemCon® Bandage, GuardaCare™ and ChitoGauze™ product lines and will begin sales through Zeria's subsidiary, Zeria Shoji Co., Ltd.
The Federal Communications Commission awarded UVA Health $767,139 this week to expand UVA's use of telehealth for patient care during the COVID-19 pandemic.
› Verified 2 days ago
Entity Name | Integris Ambulatory Care Corporation |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1750333936 PECOS PAC ID: 2365408465 Enrollment ID: O20041209000354 |
News Archive
A U.S. government report released Tuesday says that a record number of Americans are getting tested for HIV but more than 200,000 Americans are infected and are unaware of their status. In 2009 82.9 million adults age 18 to 64 had been tested for HIV. This is 11.4 million more than the total in 2006. Also until 2009 45 percent of adults had been tested at least once in their lives, up from 40 percent four years ago. However 55 percent of adults, and 28.3 percent of adults at risk for HIV, have never been tested, according to the report.
Due to the rarity of advanced cutaneous squamous cell carcinoma (cSCC), staying current with the latest information on diagnosing, treating, and supporting patients with this diagnosis can be challenging for clinicians who do not often encounter advanced cSCC in practice.
Clinical Data, Inc. (NASDAQ: CLDA) today announced the Company's operational and financial results for its third fiscal quarter ended December 31, 2009, confirming its plans to submit a new drug application (NDA) for vilazodone for the treatment of depression this quarter.
HemCon Medical Technologies, Inc. is pleased to announce that its partner in Japan, Zeria Pharmaceutical Co., Ltd., has obtained regulatory clearance from the Ministry of Health Labor and Welfare for the HemCon® Bandage, GuardaCare™ and ChitoGauze™ product lines and will begin sales through Zeria's subsidiary, Zeria Shoji Co., Ltd.
The Federal Communications Commission awarded UVA Health $767,139 this week to expand UVA's use of telehealth for patient care during the COVID-19 pandemic.
› Verified 2 days ago
Entity Name | Kidney Specialists Of Central Oklahoma, Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1710918420 PECOS PAC ID: 7618904988 Enrollment ID: O20050719000901 |
News Archive
A U.S. government report released Tuesday says that a record number of Americans are getting tested for HIV but more than 200,000 Americans are infected and are unaware of their status. In 2009 82.9 million adults age 18 to 64 had been tested for HIV. This is 11.4 million more than the total in 2006. Also until 2009 45 percent of adults had been tested at least once in their lives, up from 40 percent four years ago. However 55 percent of adults, and 28.3 percent of adults at risk for HIV, have never been tested, according to the report.
Due to the rarity of advanced cutaneous squamous cell carcinoma (cSCC), staying current with the latest information on diagnosing, treating, and supporting patients with this diagnosis can be challenging for clinicians who do not often encounter advanced cSCC in practice.
Clinical Data, Inc. (NASDAQ: CLDA) today announced the Company's operational and financial results for its third fiscal quarter ended December 31, 2009, confirming its plans to submit a new drug application (NDA) for vilazodone for the treatment of depression this quarter.
HemCon Medical Technologies, Inc. is pleased to announce that its partner in Japan, Zeria Pharmaceutical Co., Ltd., has obtained regulatory clearance from the Ministry of Health Labor and Welfare for the HemCon® Bandage, GuardaCare™ and ChitoGauze™ product lines and will begin sales through Zeria's subsidiary, Zeria Shoji Co., Ltd.
The Federal Communications Commission awarded UVA Health $767,139 this week to expand UVA's use of telehealth for patient care during the COVID-19 pandemic.
› Verified 2 days ago
Mailing Address | Practice Location Address |
---|---|
Aly E Aly, MD 3366 Nw Expressway Bldg D, Suite 730, Oklahoma City, OK 73112-4462 Ph: (405) 951-4944 | Aly E Aly, MD 3366 Nw Expressway Bldg D, Suite 730, Oklahoma City, OK 73112-4462 Ph: (405) 951-4944 |
News Archive
A U.S. government report released Tuesday says that a record number of Americans are getting tested for HIV but more than 200,000 Americans are infected and are unaware of their status. In 2009 82.9 million adults age 18 to 64 had been tested for HIV. This is 11.4 million more than the total in 2006. Also until 2009 45 percent of adults had been tested at least once in their lives, up from 40 percent four years ago. However 55 percent of adults, and 28.3 percent of adults at risk for HIV, have never been tested, according to the report.
Due to the rarity of advanced cutaneous squamous cell carcinoma (cSCC), staying current with the latest information on diagnosing, treating, and supporting patients with this diagnosis can be challenging for clinicians who do not often encounter advanced cSCC in practice.
Clinical Data, Inc. (NASDAQ: CLDA) today announced the Company's operational and financial results for its third fiscal quarter ended December 31, 2009, confirming its plans to submit a new drug application (NDA) for vilazodone for the treatment of depression this quarter.
HemCon Medical Technologies, Inc. is pleased to announce that its partner in Japan, Zeria Pharmaceutical Co., Ltd., has obtained regulatory clearance from the Ministry of Health Labor and Welfare for the HemCon® Bandage, GuardaCare™ and ChitoGauze™ product lines and will begin sales through Zeria's subsidiary, Zeria Shoji Co., Ltd.
The Federal Communications Commission awarded UVA Health $767,139 this week to expand UVA's use of telehealth for patient care during the COVID-19 pandemic.
› Verified 2 days ago
Evelyn Lorents, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 920 Sl Young Blvd, Oklahoma City, OK 73104 Phone: 405-271-5963 | |
Patrick Bronson Reeves, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 3366 Nw Expressway Ste 550, Oklahoma City, OK 73112 Phone: 405-942-5442 Fax: 405-942-6448 | |
Dr. Jake Lee Evans, MD Nephrology Medicare: Not Enrolled in Medicare Practice Location: 800 Stanton L Young Blvd, Aat 6300, Oklahoma City, OK 73104 Phone: 405-271-5963 | |
Metri Haddaden, MD Nephrology Medicare: Medicare Enrolled Practice Location: 800 Stanton L Young Blvd # 8425, Oklahoma City, OK 73104 Phone: 405-271-6173 Fax: 410-554-2184 | |
Divya Sharma Divyadarshini, MD Nephrology Medicare: Not Enrolled in Medicare Practice Location: 800 Stanton L Young Blvd, Oklahoma City, OK 73104 Phone: 405-271-5963 | |
Dr. Philip Barton Miner, Jr., M.D. Nephrology Medicare: Not Enrolled in Medicare Practice Location: 1000 N Lincoln Blvd, Suite 210, Oklahoma City, OK 73104 Phone: 405-271-4644 Fax: 405-271-3296 | |
Gary Lee Worcester, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 3433 Nw 56th St, Ste 400, Oklahoma City, OK 73112 Phone: 405-947-3341 |